You are here

  • Home
  • Archive
  • Volume 32, Issue 1
  • British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic

Article Text

Article menu
Download PDFPDF
Consensus statement
British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic
  1. Alexandra Taylor1,
  2. Sudha S Sundar2,
  3. Rebecca Bowen3,
  4. Rick Clayton4,
  5. Sarah Coleridge5,
  6. Christina Fotopoulou6,
  7. Sadaf Ghaem-Maghami6,
  8. Jonathan Ledermann7,
  9. Ranjit Manchanda8,
  10. Hilary Maxwell9,
  11. Agnieszka Michael10,
  12. Tracie Miles11,
  13. Shibani Nicum12,
  14. Andrew Nordin13,
  15. Bruce Ramsay14,
  16. Stuart Rundle15,
  17. Sarah Williams2,
  18. Nicholas J Wood16,
  19. Dennis Yiannakis16 and
  20. Jo Morrison17
  1. 1 Department of Gynaecology Oncology, Royal Marsden Hospital NHS Trust, London, UK
  2. 2 Department of Gynaecological Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  3. 3 Department of Medical Oncology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK
  4. 4 Department of Gynaecology Oncology, Manchester University NHS Foundation Trust, Manchester, UK
  5. 5 Department of Gynaecology, Nottingham University Hospitals NHS Trust, Nottingham, Nottingham, UK
  6. 6 Department of Gynaecology Oncology, Imperial College Healthcare NHS Trust, London, UK
  7. 7 Department of Medical Oncology, UCL Cancer Institute, London, UK
  8. 8 Department of Gynaecological Oncology, Barts Health NHS Trust, London, UK
  9. 9 Department of Women's Health, Dorset County Hospital NHS Foundation Trust, Dorchester, Dorset, UK
  10. 10 Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, UK
  11. 11 Department of Gynaecology Oncology, Royal United Hospital Bath NHS Trust, Bath, UK
  12. 12 Department of Medical Oncology, Oxford University Hospitals NHS Trust, Oxford, UK
  13. 13 Department of Gynaecology Oncology, East Kent Hospitals University NHS Foundation Trust, Canterbury, Kent, UK
  14. 14 Department of Gynaecology Oncology, North West Anglia NHS Foundation Trust, Peterborough, Cambridgeshire, UK
  15. 15 Department of Gynaecology Oncology, Gateshead Health NHS Foundation Trust, Gateshead, UK
  16. 16 Department of Gynaecology Oncology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK
  17. 17 Department of Gynaecology Oncology, Taunton and Somerset NHS Foundation Trust, Taunton, Somerset, UK
  1. Correspondence to Dr Alexandra Taylor, Royal Marsden Hospital NHS Trust, London SW3 6JJ, UK; alexandra.taylor{at}rmh.nhs.uk

Abstract

During the COVID-19 pandemic, pressures on clinical services required adaptation to how care was prioritised and delivered for women with gynecological cancer. This document discusses potential ‘salvage’ measures when treatment has deviated from the usual standard of care. The British Gynaecological Cancer Society convened a multidisciplinary working group to develop recommendations for the onward management and follow-up of women with gynecological cancer who have been impacted by a change in treatment during the pandemic. These recommendations are presented for each tumor type and for healthcare systems, and the impact on gynecological services are discussed. It will be important that patient concerns about the impact of COVID-19 on their cancer pathway are acknowledged and addressed for their ongoing care.

  • COVID-19

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

https://doi.org/10.1136/ijgc-2021-002942

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @ProfManchanda, @DrJoMorrison1

    • Contributors AT, JM, SSS jointly chaired the group and are responsible for final manuscript collation. All authors contributed to the development of recommendations, literature review, and manuscript development.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.